EDWARD TRIBUZIO: Open Payments
NPI 1174501571 · FERNANDINA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 53 payments from 16 companies in 2025. Trend: 2023 $1,307 · 2024 $1,587 · 2025 $1,008
Food & beverage: $923Education: $85
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $182 |
| ABBVIE INC. | 9 | $153 |
| Novo Nordisk Inc | 7 | $113 |
| Astellas Pharma US Inc | 2 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $99 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| Radius Health, Inc. | 1 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
Products named: MOUNJARO, Kerendia, VRAYLAR, LINZESS, GVOKE HYPOPEN, TRELEGY ELLIPTA, SHINGRIX, GEMTESA.
Industry payments across FL — which companies pay providers there.
